DigiPharm Europe 2010 Pt 5

Once more unto the DigiPharm breach. Part 1 Part 2 Part 3 Part 4 Part 6 Part 7 Building up to reportable adverse events When last we spoke, I covered patient community discussions. We now turn our attention to reportable adverse events and the Internet presented by Daniel Ghinn and Paul Grant. They start by […]

Read More DigiPharm Europe 2010 Pt 5

DigiPharm Europe 2010 Pt 4

And to the next instalment of this series on DigiPharm Europe 2010. Part 1 Part 2 Part 3 Part 5 Part 6 Part 7 When is a community not a community? The session entitled “Community management in Pharma” was presented by René Vvan den Bos and Erik Van der Zijden. They focused on mythical ailment […]

Read More DigiPharm Europe 2010 Pt 4

Over the falls

So I’ll begin my first blog post to say that, ashamedly, I have been a voracious consumer of content surrounding digital and social media in the pharmaceuticals industry, but never really one to engage. For example, I have accounts on all the major networking tools such as LinkedIn, Twitter, Facebook etc, but I primarily use […]

Read More Over the falls